SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-113423
Filing Date
2018-04-11
Accepted
2018-04-11 06:05:55
Documents
3
Period of Report
2018-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d567562d8k.htm 8-K 20598
2 EX-99.1 d567562dex991.htm EX-99.1 10680
3 GRAPHIC g567562g62j54.jpg GRAPHIC 18240
  Complete submission text file 0001193125-18-113423.txt   58042
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 18749095
SIC: 2834 Pharmaceutical Preparations